ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: William Blot, Michael Grever, Others To Leave NCI; RAC Approves Naked DNA Vaccine Trial

June 17, 1994

Roswell Park Instigators Find Improved Treatment For Bladder Cancer

May 23, 1975

NCI Programs: Colorectal Cancer Progress Review Group To Assess Research

October 1, 1999

NCI Plans Briefing Oct. 8 In St. Louis for SPORE Applicants

August 23, 1991

As MD Anderson Targets Eight Cancers, Detailed War Plan Remains Under Wraps

September 21, 2012

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009